<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM CHESAPEAKE BIOLOGICAL LAB AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <CIK> 0000799485 <NAME> CHESAPEAKE BIOLOGICAL LABS <MULTIPLIER> 1,000 <PERIOD-TYPE> 6-MOS <FISCAL-YEAR-END> MAR-31-2001 <PERIOD-START> APR-01-2000 <PERIOD-END> SEP-30-2000 <CASH> 192 <SECURITIES> 0 <RECEIVABLES> 3,156 <ALLOWANCES> 55 <INVENTORY> 1,464 <CURRENT-ASSETS> 5,661 <PP&E> 13,899 <DEPRECIATION> 3,617 <TOTAL-ASSETS> 17,144 <CURRENT-LIABILITIES> 3,297 <BONDS> 6,503 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 59 <OTHER-SE> 7,173 <TOTAL-LIABILITY-AND-EQUITY> 17,114 <SALES> 8,090 <TOTAL-REVENUES> 8,090 <CGS> 5,691 <TOTAL-COSTS> 6,815 <OTHER-EXPENSES> 0 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 305 <INCOME-PRETAX> 993 <INCOME-TAX> 407 <INCOME-CONTINUING> 586 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 586 <EPS-BASIC> .100 <EPS-DILUTED> .080